Alzheimer’s

Følg
Scientist in lab examining a mouse with nanobody diagrams in background, illustrating promising research on camelid antibodies for brain disorders.
Bilde generert av AI

Camelid nanobodies show promise for brain disorders in mice, review says

Rapportert av AI Bilde generert av AI Faktasjekket

A Cell Press review published on November 5, 2025, highlights tiny camelid-derived antibodies known as nanobodies as potential tools for treating conditions such as Alzheimer’s disease and schizophrenia. The authors say these proteins can reach brain targets in mice more readily than conventional antibodies and outline key steps before human testing.

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis